RESUMO
The aim of this paper was to check the possible interaction of two of the four purinergic P1 receptors, the A2A and the A3. Discovery of the A2A-A3 receptor complex was achieved by means of immunocytochemistry and of bioluminescence resonance energy transfer. The functional properties and heteromer print identification were addressed by combining binding and signaling assays. The physiological role of the novel heteromer is to provide a differential signaling depending on the pre-coupling to signal transduction components and/or on the concentration of the endogenous agonist. The main feature was that the heteromeric context led to a marked decrease of the signaling originating at A3 receptors. Interestingly from a therapeutic point of view, A2A receptor antagonists overrode the blockade, thus allowing A3 receptor-mediated signaling. The A2A-A3 receptor heteromer print was detected in primary cortical neurons. These and previous results suggest that all four adenosine receptors may interact with each other. Therefore, each adenosine receptor could form heteromers with distinct properties, expanding the signaling outputs derived from the binding of adenosine to its cognate receptors.
Assuntos
Mapas de Interação de Proteínas , Receptor A2A de Adenosina/metabolismo , Receptor A3 de Adenosina/metabolismo , Animais , Células Cultivadas , Células HEK293 , Humanos , Camundongos , Neurônios/metabolismo , Receptor A2A de Adenosina/análise , Receptor A3 de Adenosina/análise , Transdução de SinaisRESUMO
Molecular imaging probes such as PET-tracers have the potential to improve the accuracy of tumor characterization by directly visualizing the biochemical situation. Thus, molecular changes can be detected early before morphological manifestation. The A3 adenosine receptor (A3AR) is described to be highly expressed in colon cancer cell lines and human colorectal cancer (CRC), suggesting this receptor as a tumor marker. The aim of this preclinical study was the evaluation of [18F]FE@SUPPY as a PET-tracer for CRC using in vitro imaging and in vivo PET imaging. First, affinity and selectivity of FE@SUPPY and its metabolites were determined, proving the favorable binding profile of FE@SUPPY. The human adenocarcinoma cell line HT-29 was characterized regarding its hA3AR expression and was subsequently chosen as tumor graft. Promising results regarding the potential of [18F]FE@SUPPY as a PET-tracer for CRC imaging were obtained by autoradiography as ≥2.3-fold higher accumulation of [18F]FE@SUPPY was found in CRC tissue compared to adjacent healthy colon tissue from the same patient. Nevertheless, first in vivo studies using HT-29 xenografts showed insufficient tumor uptake due to (1) poor conservation of target expression in xenografts and (2) unfavorable pharmacokinetics of [18F]FE@SUPPY in mice. We therefore conclude that HT-29 xenografts are not adequate to visualize hA3ARs using [18F]FE@SUPPY.
Assuntos
Neoplasias Colorretais/diagnóstico por imagem , Ácidos Nicotínicos/farmacocinética , Tomografia por Emissão de Pósitrons/métodos , Animais , Radioisótopos de Flúor , Células HT29 , Xenoenxertos , Humanos , Camundongos , Imagem Molecular/métodos , Proteínas de Neoplasias/análise , Proteínas de Neoplasias/metabolismo , Compostos Radiofarmacêuticos/farmacocinética , Receptor A3 de Adenosina/análise , Receptor A3 de Adenosina/metabolismoRESUMO
A functional genomics approach was used to examine the immune response for transcriptional profiling of PBMC M. bovis infected cattle and healthy control cattle to stimulation with bovine tuberculin (purified protein derivative PPD-b). Total cellular RNA was extracted from non-challenged control and M. bovis challenged MDM for all animals at intervals of 6 h post-challenge, in response to in-vitro challenge with M. bovis (multiplicity of infection 2:1) and prepared for global gene expression analysis using the Agilent Bovine (V2) Gene Expression Microarray, 8 × 60 K. The pattern of expression of these genes in PPD bovine stimulated PBMC provides the first description of an M. bovis specific signature of infection that may provide insights into the molecular basis of the host response to infection. Analysis of these mapped reads showed 2450 genes (1291 up regulated and 1158 down regulated) 462 putative natural antisense transcripts (354 up-regulated and 108 down regulated) that were differentially expressed based on sense and antisense strand data, respectively (adjusted P-value ≤ 0.05). The results provided enrichment for genes involved top ten up regulated and down regulated panel of genes, including transcription factors proliferation of T and B lymphocytes. The highest differentially-expressed genes were associated to immune and inflammatory responses, immunity, differentiation, cell growth, apoptosis, cellular trafficking and regulation of lipolysis and thermogenesis. Microarray results were confirmed in infected cattle by RT qPCR to identify potential biomarkers TLR2, CD80, NFKB1, IL8, CXCL6 and ADORA3 of bovine tuberculosis.
Assuntos
Interações Hospedeiro-Patógeno/genética , Interações Hospedeiro-Patógeno/imunologia , Macrófagos/fisiologia , Mycobacterium bovis/imunologia , Tuberculina/imunologia , Tuberculina/farmacologia , Animais , Antígeno B7-1/análise , Biomarcadores , Bovinos , Proliferação de Células/efeitos dos fármacos , Quimiocina CXCL6/análise , Regulação para Baixo , Feminino , Perfilação da Expressão Gênica/veterinária , Regulação da Expressão Gênica , Interleucina-8/análise , Leucócitos Mononucleares/efeitos dos fármacos , Leucócitos Mononucleares/imunologia , Leucócitos Mononucleares/metabolismo , Macrófagos/microbiologia , Mycobacterium bovis/patogenicidade , Subunidade p50 de NF-kappa B/análise , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Receptor A3 de Adenosina/análise , Reação em Cadeia da Polimerase Via Transcriptase Reversa/veterinária , Receptor 2 Toll-Like/análise , Fatores de Transcrição , Tuberculose Bovina/microbiologia , Regulação para CimaRESUMO
The reference standards 4a-b, 6a-b, 7a-c, and desmethylated precursors 9a-b, 10a-b, 8a-c were synthesized from 4-methoxyaniline, ethyl 2-chloro-acetoacetate and substituted benzene-1,2-diamines with 3, 5, 6 steps in 61-67%, 34-41%, 23-31%, and with 4, 6, 7 steps in 49-57%, 28-35%, 20-27% overall chemical yield, respectively. The target tracers [(11)C]4a-b, [(11)C]6a-b, [(11)C]7a-c were synthesized from their corresponding precursors with [(11)C]CH3OTf through O-[(11)C]methylation and isolated by simplified SPE in 40-60% decay corrected radiochemical yields at EOB, with 185-370 GBq/µmol specific activity at EOS.
Assuntos
Radioisótopos de Carbono/química , Quinoxalinas/síntese química , Compostos Radiofarmacêuticos/síntese química , Receptor A3 de Adenosina/análise , Triazóis/síntese química , Marcação por Isótopo/métodos , Espectroscopia de Ressonância Magnética , Tomografia por Emissão de Pósitrons/métodos , Quinoxalinas/química , Compostos Radiofarmacêuticos/química , Espectrometria de Massas por Ionização por Electrospray , Triazóis/químicaRESUMO
To date, four subtypes of adenosine receptors have been cloned (A(1)R, A(2A)R, A(2B)R, and A(3)R). In a previous study we used confocal immunocytochemistry to identify A(1)R and A(2A)R receptors at mouse neuromuscular junctions (NMJs). The data shows that these receptors are localized differently in the three cells (muscle, nerve and glia) that configure the NMJs. A(1)R localizes in the terminal teloglial Schwann cell and nerve terminal, whereas A(2A)R localizes in the postsynaptic muscle and in the axon and nerve terminal. Here, we use Western blotting to investigate the presence of A(2B)R and A(3)R receptors in striated muscle and immunohistochemistry to localize them in the three cells of the adult neuromuscular synapse. The data show that A(2B)R and A(3)R receptors are present in the nerve terminal and muscle cells at the NMJs. Neither A(2B)R nor A(3)R receptors are localized in the Schwann cells. Thus, the four subtypes of adenosine receptors are present in the motor endings. The presence of these receptors in the neuromuscular synapse allows the receptors to be involved in the modulation of transmitter release.
Assuntos
Junção Neuromuscular/química , Receptor A2B de Adenosina/análise , Receptor A3 de Adenosina/análise , Animais , Western Blotting , Imuno-Histoquímica , Masculino , Camundongos , Células Musculares/química , Neuroglia/química , Neurônios/químicaRESUMO
The synthesis of reference standards and expected in vivo metabolites of the first adenosine A3 PET radiotracer [18F]FE@SUPPY ([18F]fluoroethyl 4,6-diethyl-5-[(ethyl-sulfanyl)carbonyl]-2-phenylpyridine-3-carboxylate) was achieved by using a straightforward microwave assisted alkylation method, which allowed O/S-chemoselective alkylation of the starting material 1 to give each target compound 2-8 in a single step.
Assuntos
Radioisótopos de Flúor/química , Ácidos Nicotínicos/síntese química , Receptor A3 de Adenosina/análise , Humanos , Micro-Ondas , Tomografia por Emissão de Pósitrons , Padrões de Referência , Relação Estrutura-AtividadeRESUMO
The goal of the present study was to design small, functionalized green-emitting BODIPY dyes, which can readily be coupled to target molecules such as receptor ligands, or even be integrated into their pharmacophores. A simple two-step one-pot procedure starting from 2,4-dimethylpyrrole and ω-bromoalkylcarboxylic acid chlorides was used to obtain new ω-bromoalkyl-substituted BODIPY fluorophores (1a-1f) connected via alkyl spacers of different length to the 8-position of the fluorescent dye. The addition of radical inhibitors reduced the amount of side products. The ω-bromoalkyl-substituted BODIPYs were further converted to introduce various functional groups: iodo-substituted dyes were obtained by Finkelstein reaction in excellent yields; microwave-assisted reaction with methanolic ammonia led to fast and clean conversion to the amino-substituted dyes; a hydroxyl-substituted derivative was prepared by reaction with sodium ethylate, and thiol-substituted BODIPYs were obtained by reaction of 1a-1f with potassium thioacetate followed by alkaline cleavage of the thioesters. Water-soluble derivatives were prepared by introducing sulfonate groups into the 2- and 6-position of the BODIPY core. The synthesized BODIPY derivatives showed high fluorescent yields and appeared to be stable under basic, reducing and oxidative conditions. As a proof of concept, 2-thioadenosine was alkylated with bromoethyl-BODIPY 1b. The resulting fluorescent 2-substituted adenosine derivative 15 displayed selectivity for the A3 adenosine receptor (ARs) over the other AR subtypes, showed agonistic activity, and may thus become a useful tool for studying A3ARs, or a lead structure for further optimization. The new functionalized dyes may be widely used for fluorescent labeling allowing the investigation of biological targets and processes.
Assuntos
Compostos de Boro/síntese química , Fluorescência , Corantes Fluorescentes/síntese química , Receptor A3 de Adenosina/análise , Coloração e Rotulagem , Compostos de Boro/química , Compostos de Boro/farmacologia , Corantes Fluorescentes/química , Corantes Fluorescentes/farmacologia , Ligantes , Receptor A3 de Adenosina/metabolismo , Relação Estrutura-AtividadeRESUMO
Various fluorescent nucleoside agonists of the A3 adenosine receptor (AR) were compared as high affinity probes using radioligands and flow cytometry (FCM). They contained a fluorophore linked through the C2 or N(6) position and rigid A3AR-enhancing (N)-methanocarba modification. A hydrophobic C2-(1-pyrenyl) derivative MRS5704 bound nonselectively. C2-Tethered cyanine5-dye labeled MRS5218 bound selectively to hA3AR expressed in whole CHO cells and membranes. By FCM, binding was A3AR-mediated (blocked by A3AR antagonist, at least half through internalization), with t1/2 for association 38min in mA3AR-HEK293 cells; 26.4min in sucrose-treated hA3AR-CHO cells (Kd 31nM). Membrane binding indicated moderate mA3AR affinity, but not selectivity. Specific accumulation of fluorescence (50nM MRS5218) occurred in cells expressing mA3AR, but not other mouse ARs. Evidence was provided suggesting that MRS5218 detects endogenous expression of the A3AR in the human promyelocytic leukemic HL-60 cell line. Therefore, MRS5218 promises to be a useful tool for characterizing the A3AR.
Assuntos
Agonistas do Receptor A3 de Adenosina/metabolismo , Citometria de Fluxo/métodos , Receptor A3 de Adenosina/análise , Animais , Células CHO , Cricetinae , Cricetulus , Corantes Fluorescentes , Células HL-60 , Humanos , Camundongos , Microscopia de Fluorescência , Ensaio Radioligante , Receptor A3 de Adenosina/metabolismoRESUMO
BACKGROUND: Adenosine receptors (A1, A2A, A2B, A3) play an important role in the regulation of growth, proliferation and death of cancer and normal cells. We recently showed the expression profile of A2A and A2B receptors in normal and tumor breast tissues. In the present study, we used semiquantitative RT-PCR to measure the A1 and A3 gene expression levels in normal and tumor breast tissues. METHODS: Breast tumors (n = 18) and non-neoplastic mammary tissues (n = 10) were collected and histologically confirmed to be neoplastic or non-neoplastic, respectively. Total RNA was extracted and reverse transcribed into cDNA, and PCR was performed under optimized condition for each receptor subtype. Amplification of beta-actin mRNA served as control for RT-PCR. The PCR products were separated on 1.7% agarose gels. The intensity of the bands was quantitated with ImageJ software after normalization against beta-actin expression. RESULTS: All breast tumor and normal tissue specimens expressed A1 and A3 adenosine receptor transcripts. However, we observed that the expression level of the A3 receptor in tumor tissues was 1.27-fold that of normal tissues, whereas there was no significant difference between the expression levels of A1 in normal and tumor tissues. CONCLUSIONS: Interestingly, the results of the present study indicate that breast tumors exhibit a higher level of A3 transcripts (than normal tissues) and support the possible key role of A3 adenosine receptor in tumor development. However, further studies based on real-time quantitative RT-PCR are needed to identify the exact gene expression levels.
Assuntos
Neoplasias da Mama/química , Receptor A1 de Adenosina/análise , Receptor A3 de Adenosina/análise , Adulto , Idoso , Mama/química , DNA Complementar/análise , Eletroforese em Gel de Ágar , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Pessoa de Meia-Idade , RNA Mensageiro/análise , Receptor A1 de Adenosina/genética , Receptor A3 de Adenosina/genética , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
OBJECTIVE: To elucidate the aetiology of periodontitis, this study focused on the adenosine receptor (AR) expression profiles (A1AR, A2AAR, A2BAR and A3AR) in periodontal diseased tissues. METHODS: Adenosine receptor gene expression levels in human gingiva from 15 patients with healthy gingival tissues (control group) and 15 patients who exhibited severe chronic periodontitis (test group) were measured using quantitative reverse transcription-polymerase chain reaction (RT-PCR). RESULTS: The mRNA expression pattern changed in human chronic periodontitis: the A1AR decreased 20%, A2AAR increased 2.5-fold, A2BAR increased 3.7-fold and A3AR decreased 70% as compared with that of healthy gingiva. CONCLUSION: Inflammation of the gingival tissue is associated with (1) an unchanged expression of A1AR, (2) an increased expression of A2AAR and A2BAR, and (3) a decreased expression of A3AR. Logistic regression analysis indicated that the change in the expression patterns can be used to diagnose/predict periodontitis. This finding indicates that the adenosine receptor expression profile is changed in periodontitis with the potential for future clinical application.
Assuntos
Periodontite Crônica/metabolismo , RNA Mensageiro/análise , Receptores Purinérgicos P1/análise , Adulto , Idoso , Idoso de 80 Anos ou mais , Perda do Osso Alveolar/metabolismo , Periodontite Crônica/genética , Feminino , Gengiva/metabolismo , Hemorragia Gengival/metabolismo , Gengivite/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Perda da Inserção Periodontal/metabolismo , Reação em Cadeia da Polimerase em Tempo Real , Receptor A1 de Adenosina/análise , Receptor A1 de Adenosina/genética , Receptor A2A de Adenosina/análise , Receptor A2A de Adenosina/genética , Receptor A2B de Adenosina/análise , Receptor A2B de Adenosina/genética , Receptor A3 de Adenosina/análise , Receptor A3 de Adenosina/genética , Receptores Purinérgicos P1/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Adulto JovemRESUMO
Adenosine can induce vasodilatation and vasoconstriction of the renal afferent arteriole of the mouse. We determined here its direct effect on efferent arterioles of mouse kidneys. Using isolated-perfused cortical efferent arterioles, we measured changes in luminal diameter in response to adenosine. Extraluminal application of adenosine and cyclohexyladenosine had no effect on the luminal diameter. When the vessels were constricted by the thromboxane mimetic U46619, application of adenosine and 5'-N-ethylcarboxamido-adenosine dilated the efferent arterioles in a dose-dependent manner. We also found that the adenosine-induced vasodilatation was inhibited by the A(2)-specific receptor blocker 3,7-dimethyl-1-propargylxanthine. In the presence of this inhibitor, adenosine failed to alter the basal vessel diameter of quiescent efferent arterioles. Using primer-specific polymerase chain reaction we found that the adenosine A(1), A(2a), A(2b), and A(3) receptors were expressed in microdissected mouse efferent arterioles. We conclude that adenosine dilates the efferent arteriole using the A(2) receptor subtype at concentrations compatible with activation of the A(2b) receptor.
Assuntos
Córtex Renal/irrigação sanguínea , Receptores A2 de Adenosina/fisiologia , Vasodilatação , Adenosina/análogos & derivados , Adenosina/farmacologia , Animais , Arteríolas/química , Relação Dose-Resposta a Droga , Técnicas In Vitro , Camundongos , Reação em Cadeia da Polimerase , Receptor A1 de Adenosina/análise , Receptor A1 de Adenosina/genética , Receptor A2A de Adenosina/análise , Receptor A2A de Adenosina/genética , Receptor A2B de Adenosina/análise , Receptor A2B de Adenosina/genética , Receptor A3 de Adenosina/análise , Receptor A3 de Adenosina/genética , Receptores A2 de Adenosina/metabolismo , Vasodilatação/efeitos dos fármacosRESUMO
Adenosine plays an important role in the cardiovascular system, activating adenosine A(1), A(2A), A(2B), and A(3) receptors, and regulating blood flow either by acting directly on vascular cells or indirectly because of its effects on the central or peripheral nervous systems. The aim of the present study was to investigate whether the pattern of distribution of adenosine receptor subtypes is different on elastic and muscular, using abdominal aorta and tail arteries as models. Immunohistochemistry using anti-A(1), anti-A(2A), anti-A(2B), and anti-A(3) receptor antibodies was performed on perfused-fixed/paraffin-embedded arteries from Wistar rats. 3,3'-Diaminobenzidine tetrahydrochloride (DAB; activated by hydrogen peroxide) staining revealed significant differences in the abundance of A(1), A(2A), and A(3) receptors between abdominal aorta and tail artery and allowed the identification of distinct distribution patterns for A(1), A(2A), A(2B), and A(3) receptors in the tunica adventitia, media, and intima of muscular and elastic arteries. Data are compatible with several previous functional reports supporting that different adenosine receptor subtype expression and/or their distribution in the vessel wall may influence their respective contribution to the control of blood flow.
Assuntos
Artérias/anatomia & histologia , Receptor A1 de Adenosina/análise , Receptor A2A de Adenosina/análise , Receptor A2B de Adenosina/análise , Receptor A3 de Adenosina/análise , Animais , Biometria , Imuno-Histoquímica/métodos , Masculino , Ratos , Ratos Wistar , Coloração e Rotulagem/métodos , Cauda , Túnica Íntima/anatomia & histologia , Túnica Média/anatomia & histologiaRESUMO
G protein-coupled receptors are known to be organized within different membrane compartments or microdomains of individual cells. Here, we have used a fluorescent A3 adenosine receptor (A3-AR) agonist, ABEA-X-BY630, and the technique of fluorescence correlation spectroscopy (FCS) to investigate the diffusional characteristics of functional agonist-occupied A3-AR complexes in single living cells. In Chinese hamster ovary cells expressing the human A3-AR, the fluorescent A3-AR agonist was able to inhibit forskolin-stimulated [3H]cAMP production (pEC50=8.57), and this was antagonized by the A3-selective antagonist MRS1220 (pK(B)=9.32). The fluorescent ligand also stimulated phosphoinositide hydrolysis (pEC50=7.34). Ligand binding to the A3-AR on the membranes of single cells and subsequent increases in single cell [Ca2+]i were monitored simultaneously in real time using confocal microscopy. FCS measurements in small-membrane microdomains (approximately 0.2 microm2) revealed two agonist-occupied A3-AR components with differing diffusion characteristics (diffusion coefficients=2.65x10(-8) and 1.19x10(-9) cm2/s, respectively). The binding of ligand to these two components was reduced from 5.1 and 14.9 to 2.6 and 3.3 receptors/microm2, respectively, by MRS1220 (100 nM). These data provide direct evidence for at least two populations of agonist-occupied A3-receptor complexes, showing different motilities within the membrane of single living cells.
Assuntos
Adenosina/análogos & derivados , Compostos de Boro/química , Compostos de Boro/farmacologia , Corantes Fluorescentes/química , Corantes Fluorescentes/farmacologia , Microdomínios da Membrana/metabolismo , Receptor A3 de Adenosina/metabolismo , Adenosina/química , Adenosina/farmacologia , Agonistas do Receptor A3 de Adenosina , Animais , Ligação Competitiva , Células CHO , Cricetinae , Cricetulus , Humanos , Ligantes , Substâncias Macromoleculares/química , Substâncias Macromoleculares/metabolismo , Microdomínios da Membrana/química , Microscopia de Fluorescência/métodos , Estrutura Molecular , Receptor A3 de Adenosina/análiseRESUMO
Candidate drugs are being sought for the suppression of human erythropoiesis. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide] is a derivative of adenosine that inhibits the growth of leukaemic cell lines. To determine the effects of Cl-IB-MECA upon erythropoiesis, studies were performed by using an ex vivo culture system of primary human CD34+ cells. Cl-IB-MECA suppressed erythroblast growth and maturation at doses >/=50 mumol/l through a mechanism of cell cycle inhibition and accumulation of cells in the G1/G0 phase. These findings demonstrate that Cl-IB-MECA inhibits human erythropoiesis, and suggest that further consideration of this drug is warranted for patients with erythrocytosis or polycythemia syndromes.
Assuntos
Adenosina/análogos & derivados , Antineoplásicos/farmacologia , Eritropoese/efeitos dos fármacos , Adenosina/farmacologia , Antígenos CD34 , Apoptose/efeitos dos fármacos , Contagem de Células/métodos , Ciclo Celular/efeitos dos fármacos , Células Cultivadas , Meios de Cultura , Eritroblastos/efeitos dos fármacos , Eritropoetina , Fase G1/efeitos dos fármacos , Humanos , Reação em Cadeia da Polimerase/métodos , Receptor A3 de Adenosina/análise , Fase de Repouso do Ciclo Celular/efeitos dos fármacosRESUMO
The binding and functional properties of adenosine receptor ligands were compared in Chinese hamster ovary cells transfected with human adenosine A(3) receptors. Inhibition of [(125)I]-aminobenzyl-5'-N-methylcarboamidoadenosine ([(125)I]-AB-MECA) binding by adenosine receptor ligands was examined in membrane preparations. Inhibition of forskolin-induced cAMP accumulation by agonists was measured using a cAMP enzyme immunoassay. The rank order of agonist potency for both assays was N(6)-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (IB-MECA) > 5'-N-ethylcarboxamidoadenosine (NECA) > (-)-N(6)-[(R)-phenylisopropyl] adenosine (R-PIA) > 4-aminobenzyl-5'-N-methylcarboxamidoadenosine (AB-MECA) > N(6)-cyclopentyl adenosine (CPA) > adenosine. The radioligand binding rank order of antagonist potency was N-[9-chloro-2-(2-furanyl)[1,2,4]-triazolo[1,5-c]quinazolin-5-benzeneacetamide (MRS1220) > 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) > 8-phenyltheophylline (8-PT) > 8-(p-sulfophenyl)-theophylline (8-SPT). MRS1220 competitively inhibited the effect of IB-MECA on cAMP production, with a K(B) value of 0.35 nm. These data are characteristic of adenosine A(3) receptors. The absence of Mg(2+) and presence of guanosine 5'-(gamma-thio)triphosphate (GTPgammaS) significantly reduced agonist binding inhibition potency, indicating binding to high- and low-affinity states. The IB-MECA, NECA and R-PIA IC(50) values were greater for the cAMP assay than for radioligand binding, suggesting an efficient stimulus-response transduction pathway.
Assuntos
Adenosina/análogos & derivados , Ensaio Radioligante , Receptor A3 de Adenosina/metabolismo , Adenosina/farmacologia , Animais , Ligação Competitiva , Células CHO , Cricetinae , AMP Cíclico/biossíntese , AMP Cíclico/metabolismo , Guanosina 5'-O-(3-Tiotrifosfato)/farmacologia , Radioisótopos do Iodo , Ligantes , Cloreto de Magnésio , Quinazolinas/farmacologia , Receptor A3 de Adenosina/análise , Receptor A3 de Adenosina/efeitos dos fármacos , Proteínas Recombinantes/metabolismo , Transfecção , Triazóis/farmacologiaRESUMO
OBJECTIVE: To assess the role of adenosine receptors in the regulation of coronary microvascular permeability to porcine serum albumin (P(s)(PSA)). METHODS: Solute flux was measured in single perfused arterioles and venules isolated from pig hearts using fluorescent dye-labeled probes by microspectro-fluorometry. Messenger RNA, protein, and cellular distribution of adenosine receptors in arterioles and venules were analyzed by RT-PCR, immunoblot, and immunofluorescence. RESULTS: Control venule P(s)(PSA) (10.7 +/- 4.8 x 10(- 7) cm x s(- 1)) was greater than that of arterioles (6.4+/- 2.8 x 10(-7) cm . s(-1); p < .05). Arteriolar P(s)(PSA) decreased (p < .05) with adenosine suffusion over the range from 10(- 8) to 10(-5) M, while venular P(s)(PSA) did not change. The nonselective A(1) and A(2) receptor antagonist, 8-(p-sulfophenyl) theophylline, blocked the adenosine-induced decrease in arteriolar P(s)(PSA). Messenger RNA for adenosine A(1), A(2A), A(2B), and A(3) receptors was expressed in arterioles and venules. Protein for A(1), A(2A), and A(2B), but not A(3), was detected in both microvessel types and was further demonstrated on vascular endothelial cells. CONCLUSION: Arteriolar P(s)(PSA) decreases with adenosine suffusion but not venular P(s)(PSA). Adenosine A(1), A(2A), and A(2B) receptors are expressed in both arterioles and venules. Selective receptor-linked cellular signaling mechanisms underlying the regulation of permeability remain to be determined.